Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- P/B of 0.76 — trading below book value
- Piotroski F-Score 4/9 — moderate financial health
- Loss-making — negative ROE of -128.7%
- Revenue declining 27% annually
Evolent Health, Inc. (EVH) is a Industrials company operating in Services-Management Services, listed on the NYSE , with a market capitalisation of $316 million . Key value metrics: P/B ratio 0.76, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Evolent Health, Inc. — Fundamental Analysis Summary
On financial health, EVH shows a moderate Piotroski F-Score of 4/9, and negative return on equity of -128.7% (sector average: 5.5%), and high leverage with a debt-to-equity ratio of 2.34.
StockPik's composite Value Score for EVH is 48/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
EVH reports a thin gross margin of 12.3% (sector average: 24.7%) and a negative operating margin of -1.0%.
EVH shows revenue declining at 27% year-over-year, with earnings declining at 767%.